Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,200 | -25,780 | -3,980 | -3,790 | -3,540 |
| Depreciation Amortization | 1,650 | 2,420 | 410 | 380 | 270 |
| Other Working Capital | -4,190 | -3,630 | 400 | -590 | -2,490 |
| Other Operating Activity | 1,810 | 5,100 | 380 | 930 | 1,000 |
| Operating Cash Flow | $-3,930 | $-21,890 | $-2,790 | $-3,070 | $-4,760 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -160 | -5,140 | -690 | -960 | -870 |
| Net Acquisitions | -1,540 | -43,900 | -10 | -960 | 0 |
| Other Investing Activity | 36,630 | -28,340 | -4,480 | -13,230 | 4,960 |
| Investing Cash Flow | $34,930 | $-77,380 | $-5,180 | $-15,150 | $4,090 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -13,530 | 99,250 | 1,130 | 35,710 | -520 |
| Financing Cash Flow | $-13,530 | $99,250 | $1,130 | $35,710 | $-520 |
| Exchange Rate Effect | -80 | 520 | 250 | 270 | 0 |
| Beginning Cash Position | 8,270 | 11,990 | 24,060 | 6,410 | 7,510 |
| End Cash Position | 25,650 | 12,490 | 17,470 | 24,170 | 6,250 |
| Net Cash Flow | $17,380 | $500 | $-6,590 | $17,760 | $-1,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,930 | -21,890 | -2,790 | -3,070 | -4,760 |
| Free Cash Flow | -3,930 | -21,890 | -2,790 | -3,070 | -4,760 |